REM sleep was discovered in 1953 by Eugene Aserinsky and Nathaniel Kleitman at the University of Chicago, when they noticed that periods of rapid eye movement during sleep were reliably associated with vivid dreaming when subjects were woken. The discovery reframed sleep research: the sleeping brain was not simply off. It had distinct, biologically meaningful states, one of which was as neurologically active as wakefulness.
Neural Activity During REM
EEG readings during REM show a low-amplitude, mixed-frequency pattern that closely resembles the waking state — a stark contrast to the high-amplitude, slow-wave activity of N3 sleep. This is why REM is sometimes called "paradoxical sleep": the brain is nearly as active as during wakefulness, yet the person is deeply asleep and largely unaware of their surroundings.
The neurochemical environment of REM is distinct from both wakefulness and NREM sleep:
- Acetylcholine is at or near waking levels — high.
- Serotonin is at its lowest point of the 24-hour cycle.
- Norepinephrine is effectively absent — the locus coeruleus, the brain's main norepinephrine source, is almost completely silent during REM.
- Dopamine activity is elevated in limbic regions.
The low-norepinephrine, high-acetylcholine environment creates a neurochemical state unlike anything that occurs during wakefulness. Matthew Walker and others have argued that this unique chemical mixture — particularly the absence of norepinephrine — is what makes REM sleep specifically suited for processing emotional memories, allowing them to be re-experienced without the physiological arousal that accompanied the original experience.
REM Atonia: Why the Body Is Paralyzed
During REM sleep, voluntary muscles throughout the body enter a state of near-complete paralysis — a condition called REM atonia or REM sleep muscle atonia. The mechanism is active inhibition from the brainstem: neurons in the ventromedial medulla and the subcoeruleus region send inhibitory signals through the spinal cord that suppress motor neuron activity, preventing voluntary movement.
REM atonia serves an obvious protective function — without it, people would act out their dreams, with potentially dangerous consequences. This is precisely what happens in REM sleep behavior disorder (RBD), a parasomnia in which REM atonia fails. People with RBD physically enact their dreams — punching, kicking, shouting — while remaining asleep. RBD is significantly associated with Parkinson's disease and other synucleinopathies, often emerging years or decades before other neurological symptoms.
The muscles controlling eye movement and breathing are spared from REM atonia — the eyes dart rapidly under closed lids (the "R" in REM), and breathing continues, though it becomes somewhat irregular.
Emotional Memory Processing
One of the most clinically significant functions of REM sleep is the processing of emotional memories. Matthew Walker's "sleep to forget, sleep to remember" framework proposes that REM sleep separates the emotional tag from the memory content — preserving the narrative and factual content of emotional experiences while reducing the intensity of the emotional response to them.
The mechanism may involve the absence of norepinephrine during REM. Norepinephrine is the neurochemical most associated with stress responses and emotional arousal. Its near-total silence during REM creates a window in which emotional memories can be replayed — triggered by the associative activity of dreaming — without the physiological arousal that would normally accompany them. Each replay may slightly reduce the emotional charge, gradually integrating the memory into a less threatening context.
Evidence for this comes from studies showing that subjects who sleep normally after viewing emotionally disturbing images rate them as less emotionally distressing the following day, while those who are REM-deprived show no reduction in distress ratings. The same material, the same time elapsed, but without REM sleep, the emotional dampening does not occur.
This framework also helps explain PTSD pathology. In PTSD, sleep is severely disrupted — particularly REM sleep. Nightmares are not simply a symptom of PTSD; they may represent failed REM emotional processing, where norepinephrine (elevated in PTSD) is present during sleep and prevents the normal dampening that should occur. Prazosin, an alpha-1 blocker that reduces central norepinephrine activity, reduces nightmares in PTSD — pharmacological evidence for the norepinephrine hypothesis.
REM Sleep and Creative Thinking
The loose, associative nature of REM cognition — the qualities that produce bizarre, non-linear dream narratives — appears to have functional value for creative problem-solving. During REM, the brain activates widely distributed networks simultaneously and suppresses the prefrontal inhibitory circuits that normally gate unconventional associations. The result is a state in which the brain can find connections between distantly related concepts that the waking, analytically constrained mind would not produce.
Multiple studies support this. Denise Cai's group found that REM sleep, but not equivalent NREM sleep or quiet rest, improved creative insight on a problem-solving task that required noticing a hidden rule. Wagner and colleagues demonstrated that people who slept on a math problem — getting their morning REM — were nearly three times more likely to discover a shortcut solution than those tested without sleep.
Historical examples of insights occurring in sleep or at the threshold of sleep — the benzene ring (Kekulé), the sewing machine needle (Howe), the periodic table (Mendeleev) — fit this model. Whether these specific stories are accurate is debated, but the broader point about REM's role in creative recombination has substantial experimental support.
What Disrupts REM Sleep
REM sleep is concentrated in the final two to three hours of an eight-hour night. It is therefore disproportionately lost when sleep is cut short — an important consideration for anyone setting an early alarm.
Several substances specifically suppress REM:
- Alcohol: Dramatically suppresses REM in the first half of the night. The rebound REM in the second half (as alcohol clears) is associated with disturbing dreams and lighter, more fragmented sleep.
- Most antidepressants: SSRIs, SNRIs, MAOIs, and TCAs all significantly suppress REM sleep. This is not simply a side effect — it may be part of the mechanism by which some antidepressants work, since REM is disrupted in depression. But chronic REM suppression has cognitive and emotional consequences that are not fully understood.
- Cannabis (THC): Strongly suppresses REM sleep. Regular cannabis users who quit often experience REM rebound with intense, vivid dreaming for weeks — a feature of cannabis withdrawal that is sometimes misunderstood.
- Beta-blockers: Suppress melatonin and appear to reduce REM, possibly explaining their association with vivid dreams and nightmares.
REM sleep occupies only about 20–25% of a typical night, but it handles functions that have no waking equivalent: the decontextualization of emotional memories, the creative cross-indexing of knowledge networks, and the calibration of threat-detection systems. Losing REM — through short sleep, alcohol, or certain medications — does not simply make you tired. It leaves specific cognitive and emotional functions impaired in ways that are distinct from the effects of losing NREM sleep.